Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 1, 2010, Pages 103-113

  So, Hon Cheong ^a   Fong, Pui Y ^b   Chen, Ronald Y L ^a   Hui, Tomy C K ^a   Ng, Mandy Y M ^b   Cherny, Stacey S ^a,b,c   Mak, William W M ^b,d   Cheung, Eric F C ^e   Chan, Raymond C K ^a,f   Chen, Eric Y H ^a   Li, Tao ^g   Sham, Pak C ^a,b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Hong Kong Biotechnology Education Resource Centre   (Hong Kong)

^e CASTLE PEAK HOSPITAL   (Hong Kong)

^f INSTITUTE OF PSYCHOLOGY   (China)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CSPG5; ErbB4; Genetic association; Interaction; Neuregulin 1

Indexed keywords

METHAMPHETAMINE; NEU DIFFERENTIATION FACTOR; NEUROGLYCAN C; UNCLASSIFIED DRUG;

ARTICLE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE MAPPING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURITE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUREGULINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOCHONDROITIN SULFATES; SCHIZOPHRENIA;

RATTUS;

EID: 73949094711     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30961     Document Type: Article

References (49)

1. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, et al. 2006. Gene prioritization through genomic data fusion. Nat Biotechnol 24(5):537-544.
2. Ao SI, Yip K, Ng M, Cheung D, Fong PY, Melhado I, Sham PC. 2005. CLUSTAG: Hierarchical clustering and graph methods for selecting tag SNPs. Bioinformatics 21(8):1735-1736.
3. Aono S, Keino H, Ono T, Yasuda Y, Tokita Y, Matsui F, Taniguchi M, Sonta S, Oohira A. 2000. Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development. J Biol Chem 275(1):337-342.
4. Aston C, Jiang L, Sokolov BP. 2004. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77(6):858-866.
5. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
6. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc 57:289-300.
7. Benzel I, Bansal A, Browning BL, Galwey NW, Maycox PR, McGinnis R, Smart D, St Clair D, Yates P, Purvis I. 2007. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 3:31.
8. Cardno AG, Gottesman II. 2000. Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97(1):12-17.
9. Chen RY, Sham P, Chen EY, Li T, Cheung EF, Hui TC, Kwok CL, Lieh-Mak F, Zhao JH, Collier D, et al. 2001. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res 105(3):175-185.
10. Corfas G, Roy K, Buxbaum JD. 2004. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7(6):575-580.
11. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, Clair DS, Waddington JL, Gill M. 2004. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 9(2):208-213.
12. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
13. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, Lassmann T, Moxon S, Marshall M, Khanna A, Durbin R, et al. 2006. Pfam: Clans, web tools and services. Nucleic Acids Res 34(Database issue):D247-D251.
14. Hahn LW, Ritchie MD, Moore JH. 2003. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19(3):376-382.
15. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98(8):4746-4751.
16. Hall D, Gogos JA, Karayiorgou M. 2004. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 3(4):240-248.
17. Harrison PJ, Law AJ. 2006. Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry 60(2):132-140. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10(1):40-68, image 5.
18. Ishikawa K, Nitta A, Mizoguchi H, Mohri A, Murai R, Miyamoto Y, Noda Y, Kitaichi K, Yamada K, Nabeshima T. 2006. Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain. Int J Neuropsychopharmacol 9(4):407-415.
19. Juttner R, More MI, Das D, Babich A, Meier J, Henning M, Erdmann B,Mu Ller EC, Otto A, Grantyn R, et al. 2005. Impaired synapse function during postnatal development in the absence of CALEB, an EGF-like protein processed by neuronal activity. Neuron 46(2):233-245.
20. Kanazawa T, Glatt SJ, Tsutsumi A, Kikuyama H, Koh J, Yoneda H, Tsuang MT. 2007. Schizophrenia is not associated with the functional candidate gene ERB B3: Results from a case-control study. Am J Med Genet Part B 144B(1):113-116.
21. Karoutzou G, Emrich HM, Dietrich DE. 2008. The myelin-pathogenesis puzzle in schizophrenia: A literature review. Mol Psychiatry 13:245-260.
22. Kinugasa Y, Ishiguro H, Tokita Y, Oohira A, Ohmoto H, Higashiyama S. 2004. Neuroglycan C, a novel member of the neuregulin family. Biochem Biophys Res Commun 321(4):1045-1049.
23. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73(1):34-48.
24. Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM, Steinthorsdottir V, Januel D, Gudnadottir VG, Petursson H, et al. 2004. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry 9(7):698-704.
25. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15(12):1995-2002.
26. Maziade M, Roy MA, Rouillard E, Bissonnette L, Fournier JP, Roy A, Garneau Y, Montgrain N, Potvin A, Cliche D, et al. 2001. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: A linkage study in 13 target chromosomes. Mol Psychiatry 6(6):684-693.
27. Nakanishi K, Aono S, Hirano K, Kuroda Y, Ida M, Tokita Y, Matsui F, Oohira A. 2006. Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J Biol Chem 281(34):24970-24978.
28. Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ, Preece AC, Dwyer S, Wilkinson JC, et al. 2006. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet Part B 141B(1):96-101.
29. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. 1996. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373-1379.
30. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, Morley CP, McGann L, Gentile KL, Rockwell GN, et al. 2005. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10(4):366-374, 328.
31. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, Kimberland M, Babb R, Vourlis S, Chen H, et al. 1995. Schizophrenia: A genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60(3):252-260.
32. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. 2001. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69(1):138-147.
33. Ritchie MD, Hahn LW, Moore JH. 2003. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24(2):150-157.
34. Roeder K, Bacanu SA, Wasserman L, Devlin B. 2006. Using linkage genome scans to improve power of association in genome scans.AmJHumGenet 78(2):243-252.
35. Sawa A, Snyder SH. 2002. Schizophrenia: Diverse approaches to a complex disease. Science 296(5568):692-695.
36. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316(5829):1331-1336.
37. Schumacher S, Volkmer H, Buck F, Otto A, Tarnok A, Roth S, Rathjen FG. 1997. Chicken acidic leucine-rich EGF-like domain containing brain protein (CALEB), a neural member of the EGF family of differentiation factors, is implicated in neurite formation. J Cell Biol 136(4):895-906.
38. Sham PC, Ao SI, Kwan JS, Kao P, Cheung F, Fong PY, Ng MK. 2007. Combining functional and linkage disequilibrium information in the selection of tag SNPs. Bioinformatics 23(1):129-131.
39. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. 2006. The involvement of ErbB4 with schizophrenia: Association and expression studies. Am J Med Genet Part B 141B(2):142-148.
40. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71(4):877-892.
41. Straub RE, Weinberger DR. 2006. Schizophrenia genes - Famine to feast. Biol Psychiatry 60(2):81-83.
42. Tang JX, Chen WY, He G, Zhou J, Gu NF, Feng GY, He L. 2004. Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 9(1):11-12.
43. ThomsonPA, Christoforou A, Morris SW,Adie E, Pickard BS, Porteous DJ, Muir WJ, Blackwood DH, Evans KL. 2007. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 12(1):94-104.
44. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362(9386):798-805.
45. Toda S, McGinty JF, Kalivas PW. 2002. Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: A DNA macroarray study. J Neurochem 82(5):1290-1299.
46. Watanabe E, Maeda N, Matsui F, Kushima Y, Noda M, Oohira A. 1995. Neuroglycan C, a novel membrane-spanning chondroitin sulfate proteoglycan that is restricted to the brain. J Biol Chem 270(45):26876-26882.
47. Watanabe Y, Fukui N, Nunokawa A, Muratake T, Kaneko N, Kitamura H, Someya T. 2007. No association between the ERBB3 gene and schizophrenia in a Japanese population. Neurosci Res 57(4):574-578.
48. Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, Zhou M, Zhang HY, Kong QM, Liu C, et al. 2003. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 8(7):706-709.
49. Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N, Feng G, Zhu S, Liu H, Xing Y, et al. 2004. A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet 41(1):31-34.